Literature DB >> 9130267

Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients.

P I Oteiza1, O D Uchitel, F Carrasquedo, A L Dubrovski, J C Roma, C G Fraga.   

Abstract

Several parameters indicators of oxidative stress were evaluated in blood from individuals with the sporadic form of amyotrophic lateral sclerosis (SALS) and compared to healthy controls. Plasma levels of 2-thiobarbituric-reactive substances (TBARS), products of lipid peroxidation, were significantly higher (p < 0.03) in the SALS patients compared to controls. The concentration of plasma antioxidants (alpha-tocopherol, beta-carotene, ubiquinol-10 and glutathione) and the activity of red blood cell CuZn superoxide dismutase were not significantly different between the groups. The ratio TBARS/alpha-tocopherol was 47% higher in the SALS individuals than in controls. Protein thiols and protein-associated carbonyls in red blood cell membranes and supernates were similar for both groups. A positive correlation (r2 = 0.91) was found between the concentration of protein-associated carbonyls in red blood cells and the onset of clinical symptoms. These findings are in agreement with several reports showing higher levels of oxidative damage to cell components in ALS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130267     DOI: 10.1023/a:1027384432715

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

1.  Determination of carbonyl content in oxidatively modified proteins.

Authors:  R L Levine; D Garland; C N Oliver; A Amici; I Climent; A G Lenz; B W Ahn; S Shaltiel; E R Stadtman
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 2.  Oxidants, antioxidants, and the degenerative diseases of aging.

Authors:  B N Ames; M K Shigenaga; T M Hagen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

3.  Superoxide dismutase assays.

Authors:  L Flohé; F Otting
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

4.  Superoxide dismutase and free radicals in sporadic amyotrophic lateral sclerosis: relationship to clinical data.

Authors:  Y Ihara; A Mori; T Hayabara; M Kawai; R Namba; K Nobukuni; K Sato; M Kibata
Journal:  J Neurol Sci       Date:  1995-12       Impact factor: 3.181

5.  Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes.

Authors:  C G Fraga; B E Leibovitz; A L Tappel
Journal:  Free Radic Biol Med       Date:  1988       Impact factor: 7.376

6.  Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene.

Authors:  R A Riemersma; D A Wood; C C Macintyre; R A Elton; K F Gey; M F Oliver
Journal:  Lancet       Date:  1991-01-05       Impact factor: 79.321

7.  Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase.

Authors:  P M Andersen; P Nilsson; V Ala-Hurula; M L Keränen; I Tarvainen; T Haltia; L Nilsson; M Binzer; L Forsgren; S L Marklund
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

8.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

Authors:  H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

9.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

Review 10.  Amyotrophic lateral sclerosis is a multifactorial disease.

Authors:  A Eisen
Journal:  Muscle Nerve       Date:  1995-07       Impact factor: 3.217

View more
  14 in total

1.  The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson's disease.

Authors:  Athan Baillet; Vanessa Chanteperdrix; Candice Trocmé; Pierre Casez; Catherine Garrel; Gérard Besson
Journal:  Neurochem Res       Date:  2010-06-10       Impact factor: 3.996

Review 2.  Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders.

Authors:  Karen Berman; Henry Brodaty
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 3.  [Amyotrophic lateral sclerosis. Current clinical trials and underlying pathomechanisms].

Authors:  K Kollewe; R Dengler; S Petri
Journal:  Nervenarzt       Date:  2008-06       Impact factor: 1.214

Review 4.  Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.

Authors:  Christi Kolarcik; Robert Bowser
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

Review 5.  New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.

Authors:  Heather M Wilkins; Jill K Morris
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 6.  Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases.

Authors:  William C Ballance; Ellen C Qin; Hee Jung Chung; Martha U Gillette; Hyunjoon Kong
Journal:  Biomaterials       Date:  2019-06-21       Impact factor: 12.479

Review 7.  Amyotrophic lateral sclerosis: progress and prospects for treatment.

Authors:  Michel Dib
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  The oxidant defense system in human neuroblastoma IMR-32 cells predifferentiation and postdifferentiation to neuronal phenotypes.

Authors:  Alejandra G Erlejman; Patricia I Oteiza
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

9.  Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  Luis B Tovar-Y-Romo; Luz Diana Santa-Cruz; Ricardo Tapia
Journal:  Mol Neurodegener       Date:  2009-07-20       Impact factor: 14.195

10.  Vitamin E deficiency and risk of equine motor neuron disease.

Authors:  Hussni O Mohammed; Thomas J Divers; Brian A Summers; Alexander de Lahunta
Journal:  Acta Vet Scand       Date:  2007-07-02       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.